Rapid response to galcanezumab and predictive factors in chronic migraine patients: a 3‐month observational, longitudinal, cohort multicenter Italian real‐life study

2021 ◽  
Author(s):  
Fabrizio Vernieri ◽  
Claudia Altamura ◽  
Nicoletta Brunelli ◽  
Carmelina Maria Costa ◽  
Cinzia Aurilia ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Predictive Factors ◽  
Real Life ◽  
Rapid Response ◽  
Longitudinal Cohort ◽  
Life Study ◽  
Real Life Study

Erenumab efficacy in highly resistant chronic migraine: a real-life study

2020 ◽  
Vol 41 (S2) ◽  
pp. 457-459
Author(s):  
Umberto Pensato ◽  
Valentina Favoni ◽  
Alessia Pascazio ◽  
Matteo Benini ◽  
Gian Maria Asioli ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Real Life ◽  
Life Study ◽  
Real Life Study

Baseline data of the DEVIDE-study: DEnosumab vs Intravenous Ibandronate: a 2-year retrospective head to head real life study

2014 ◽  
Author(s):  
Karin Amrein ◽  
Christian Muschitz ◽  
Doris Wagner ◽  
Thomas R Pieber ◽  
Heinrich Resch ◽  
...  
Keyword(s):  
Real Life ◽  
Baseline Data ◽  
Life Study ◽  
Real Life Study

Pegvisomant: daily versus non daily administration a single centre real life study

2019 ◽  
Author(s):  
Francesca Dassie ◽  
Marco Rosson ◽  
Matteo Parolin ◽  
Lucia Russo ◽  
Sara Mazzocut ◽  
...  
Keyword(s):  
Real Life ◽  
Daily Administration ◽  
Single Centre ◽  
Life Study ◽  
Real Life Study
Sign in / Sign up

Export Citation Format

Share Document